Aspira Women's Health (AWH) Stock Analysis
NASDAQHealthcareMedical - Diagnostics & Research
What Aspira Women's Health does
Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, they provide ASPiRA GenetiX, a genetic screening option for assessing individual susceptibility to gynecologic cancers. The company operates Aspira Synergy, a cloud-based platform enabling decentralized access to protein biomarker and hereditary genetic testing. Furthermore, Aspira owns and manages ASPiRA LABS, a specialized laboratory dedicated to applying advanced biomarker technologies for the management of gynecologic cancers and related conditions. Its innovation pipeline features upcoming products like OVAWatch, EndoCheck, and OVAInherit. Aspira serves a diverse clientele, including individual physicians, physician office laboratories, and both national and regional laboratory networks. The company actively collaborates with several institutions, holding a research agreement with Baylor Genetics and another with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to explore microRNA technology for enhanced early ovarian cancer detection. A strategic alliance is also in place with Quest Diagnostics, Incorporated. Incorporated in 1993 and headquartered in Austin, Texas, the company adopted its current name, Aspira Women's Health Inc., in June 2020, having previously operated as Vermillion, Inc.
Key metrics
ETFs linked to AWH
Broad-market and Healthcare sector ETFs an investor holding Aspira Women's Health is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how AWH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze AWH in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Aspira Women's Health?
- Aspira Women's Health trades under the ticker AWH on NASDAQ.
- Which exchange is AWH listed on?
- AWH is listed on NASDAQ.
- What sector does Aspira Women's Health operate in?
- Aspira Women's Health is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
- How can PortView help analyze AWH in a portfolio?
- PortView shows AWH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.